Unit:
|
Fujian BerryGenomics Health Management Co., Ltd.
|
![]() |
Project Area:
|
Fuzhou-changle No. 668, Wensong Road, Wenwusha Street
|
|
Industry:
|
Biological and New Pharmaceutical Industry
|
|
Type of Project:
|
New Project
|
|
Cooperation Mode:
|
Joint Venture,Collaborate,Transfer of Technology,Introduction of Equipment,Others
|
|
Nature of Project:
|
Encourage
|
|
Working Progress in Prior Period:
|
Some buildings have been put into use and are expected to be completed in 2023
|
|
Total Investment:
|
3295.35 million yuan
|
|
Expected to Attract Investment:
|
3500 million yuan
|
Biological & New Pharmaceutical Industry
In 2024, Fujian Province had 344 pharmaceutical enterprises above designated size, generating a total revenue of RMB 60.84 billion. Our province has established a relatively comprehensive pharmaceutical industrial system, covering categories such as chemical APIs (active pharmaceutical ingredients), chemical drug preparations, biopharmaceuticals, traditional Chinese medicine (TCM) preparations, TCM decoction pieces, and medical devices. The biopharmaceutical industry in Fujian Province is primarily concentrated in Xiamen, Sanming, Fuzhou, and Zhangzhou, with these four cities accounting for approximately 80% of our province's total revenue.